new glp-1 agonists England Journalist of Medicine published great article. Read it to learn more about the science behind medications. GLP-1 receptor are increasingly used to treat type 2 diabetes and obesity Switching between GLP‐1 receptor agonists
Description
Initially developed for Type 2 Diabetes (T2D), GLP-1 drugs are now widely used in obesity/weight loss management, with emerging applications in cardiovascular and neurodegenerative diseases
Many people with obesity have fatty liver disease
You must be logged in to post a review
Trelagliptin: first global approval
Food and Drug Administration (FDA) recently approved a once-daily oral version of the Wegovy semaglutide, making it the first GLP-1 receptor agonist pill specifically approved for chronic weight management in adults with obesity, or adults who are overweight with at least one weight-related condition
